Dimitris Voliotis

Dimitris Voliotis

Director Técnico/Científico/I+D en RADIOPHARM THERANOSTICS LIMITED .
63 años
Health Technology
Consumer Services
Health Services

Perfil

Dimitris Voliotis currently works at Radiopharm Theranostics Ltd., as Chief Medical Officer from 2024.
Dr. Voliotis also formerly worked at CureVac SE, as Chief Development Officer from 2019 to 2020, Eisai, Inc., as Global Head-Clinical Development Oncology from 2016 to 2019, Bayer HealthCare AG, as Vice President & Head-Oncology Group from 2007 to 2014, and Zentalis Pharmaceuticals, Inc., as Senior Vice President-Clinical Development from 2020 to 2023.
Dr. Voliotis received his doctorate degree from Universität zu Köln.

Cargos activos de Dimitris Voliotis

EmpresasCargoInicio
RADIOPHARM THERANOSTICS LIMITED Director Técnico/Científico/I+D 20/08/2024

Antiguos cargos conocidos de Dimitris Voliotis.

EmpresasCargoFin
ZENTALIS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/09/2023
Corporate Officer/Principal 01/02/2020
Corporate Officer/Principal 01/01/2019
Corporate Officer/Principal 01/09/2014
Ver el detalle de la experiencia de Dimitris Voliotis.

Formación de Dimitris Voliotis.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

73

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

  1. Bolsa de valores
  2. Insiders
  3. Dimitris Voliotis